Investor Relations

SEC Filing Details

Document Details

Form
Filing Date
Aug 29, 2019
Document Date
Jun 30, 2019
Form Description
Amendment to a previously filed 6-K
Filing Group
Current Reports
Company
VBL Therapeutics
Issuer
Vascular Biogenics Ltd.